Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Impact of Source Control in Patients With Severe Sepsis and Septic Shock.

Martínez ML, Ferrer R, Torrents E, Guillamat-Prats R, Gomà G, Suárez D, Álvarez-Rocha L, Pozo Laderas JC, Martín-Loeches I, Levy MM, Artigas A; Edusepsis Study Group.

Crit Care Med. 2017 Jan;45(1):11-19.

PMID:
27611975
2.

Author's reply.

Azkárate I, Choperena G, Salas E, Sebastián R.

Med Intensiva. 2016 Jun-Jul;40(5):323. doi: 10.1016/j.medin.2016.03.002. Epub 2016 May 17. English, Spanish. No abstract available.

3.

Epidemiology and prognostic factors in severe sepsis/septic shock. Evolution over six years.

Azkárate I, Choperena G, Salas E, Sebastián R, Lara G, Elósegui I, Barrutia L, Eguibar I, Salaberria R.

Med Intensiva. 2016 Jan-Feb;40(1):18-25. doi: 10.1016/j.medin.2015.01.006. Epub 2015 Mar 6. English, Spanish.

4.

Antibiotic prescription patterns in the empiric therapy of severe sepsis: combination of antimicrobials with different mechanisms of action reduces mortality.

Díaz-Martín A, Martínez-González ML, Ferrer R, Ortiz-Leyba C, Piacentini E, Lopez-Pueyo MJ, Martín-Loeches I, Levy MM, Artigas A, Garnacho-Montero J; Edusepsis Study Group.

Crit Care. 2012 Nov 18;16(6):R223. doi: 10.1186/cc11869.

5.

[A prospective, observational severe sepsis/septic shock registry in a tertiary hospital in the province of Guipuzcoa (Spain)].

Azkárate I, Sebastián R, Cabarcos E, Choperena G, Pascal M, Salas E.

Med Intensiva. 2012 May;36(4):250-6. doi: 10.1016/j.medin.2011.10.006. Epub 2011 Dec 6. Spanish.

6.

Cost-effectiveness of the Surviving Sepsis Campaign protocol for severe sepsis: a prospective nation-wide study in Spain.

Suarez D, Ferrer R, Artigas A, Azkarate I, Garnacho-Montero J, Gomà G, Levy MM, Ruiz JC; Edusepsis Study Group.

Intensive Care Med. 2011 Mar;37(3):444-52. doi: 10.1007/s00134-010-2102-3. Epub 2010 Dec 9.

PMID:
21152895
7.

[Impact of primary and intravascular catheter-related bacteremia due to coagulase-negative staphylococci in critically ill patients].

Olaechea PM, Alvarez-Lerma F, Palomar M, Insausti J, López-Pueyo MJ, Martínez-Pellús A, Cantón ML; Grupo ENVIN-HELICS.

Med Intensiva. 2011 May;35(4):217-25. doi: 10.1016/j.medin.2010.09.002. Epub 2010 Dec 3. Spanish.

8.

Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study.

Ferrer R, Artigas A, Suarez D, Palencia E, Levy MM, Arenzana A, Pérez XL, Sirvent JM; Edusepsis Study Group.

Am J Respir Crit Care Med. 2009 Nov 1;180(9):861-6. doi: 10.1164/rccm.200812-1912OC. Epub 2009 Aug 20.

PMID:
19696442
9.

Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain.

Ferrer R, Artigas A, Levy MM, Blanco J, González-Díaz G, Garnacho-Montero J, Ibáñez J, Palencia E, Quintana M, de la Torre-Prados MV; Edusepsis Study Group.

JAMA. 2008 May 21;299(19):2294-303. doi: 10.1001/jama.299.19.2294.

PMID:
18492971
10.

[Spontaneous splenic rupture secondary to Salmonella typhi infection].

Azkarate I, Amato E, Neira F, Gorospe A.

Enferm Infecc Microbiol Clin. 1993 Jan;11(1):54-5. Spanish. No abstract available.

PMID:
8461376

Supplemental Content

Loading ...
Support Center